Endocyte: 2Q Earnings Snapshot

July 31, 2018

WEST LAFAYETTE, Ind. (AP) _ Endocyte Inc. (ECYT) on Tuesday reported a loss of $11.6 million in its second quarter.

On a per-share basis, the West Lafayette, Indiana-based company said it had a loss of 17 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The biopharmaceutical company posted revenue of $14,000 in the period.

Endocyte shares have more than tripled since the beginning of the year. The stock has climbed tenfold in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ECYT at https://www.zacks.com/ap/ECYT

Update hourly